IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

biote Corp. (BTMD)

Medicinal Chemicals & Botanical Products

Latest Price
$1.40
TTM P/E
14.00
Normalized P/E
--
Div Yield
--
Book Value
--
P/B Ratio
--

Valuation metrics

adjust assumptions →
Norm. op. income: $29M (median of 5yr)
Tax rate: 19%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$2.62
+87% upside
Base FCF: $30M (median of recent 4yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$7.48
+434% upside
EPS: $0.74
Target P/E: 14×
Formula: EPS × P/E
P/E Fair Value
$10.36
+640% upside

Institutional Ownership

41.8% held by institutions
InstitutionSharesValueOwnership %ChangeFiling Date
325 CAPITAL LLC4.55M$8.0M15.35%--2026-06-30
Bandera Partners LLC2.07M$3.0M6.97%--2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC1.10M$2.0M3.72%-11.1K2026-06-30
MILLENNIUM MANAGEMENT LLC436.1K--1.47%+420.8K2026-06-30
DIMENSIONAL FUND ADVISORS LP432.0K--1.46%-111.5K2026-06-30
BlackRock, Inc.365.9K--1.24%-1.37M2026-06-30
CITADEL ADVISORS LLC301.3K--1.02%+217.0K2026-06-30
RICE HALL JAMES & ASSOCIATES, LLC262.8K--0.89%+12.8K2026-06-30
GEODE CAPITAL MANAGEMENT, LLC260.5K--0.88%-355.2K2026-06-30
JANE STREET GROUP, LLC253.3K--0.85%+203.9K2026-06-30
View all institutional holders →